IP Library Granted Patent US 8,846,349
Granted Patent B2
US 8,846,349 · App. 12/839,837 · Granted Sep 30, 2014

Sequences and their use for detection and characterization of

Inventor: Frank R. Burns (Philadelphia, PA)
Assignee: E.I. du Pont de Nemours and Company
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,846,349
App. No.
12/839,837
Granted
Sep 30, 2014
Kind
B2
Abstract

This invention relates to a rapid method for detection and characterization of Escherichia coli bacteria serotype O157:H7 based on the presence of nucleic acid sequences, in particular, to a PCR-based method for detection, and to oligonucleotide molecules and reagents and kits useful therefore. This method is preferably employed to detect E. coli O157:H7 in a food or water sample, such as a beef enrichment. The present invention further relates to replication compositions and kits for carrying out the method of the present invention.

Claims (22)

1. A method for detecting the presence of E. coli O157:H7 in a sample, said sample comprising nucleic acids, said method comprising:

(a) providing a reaction mixture comprising suitable primer pairs for amplification of at least a portion of

(i) two or more E. coli O157:H7 genomic DNA regions within the pO157 portion of the E. coli O157:H7 genome, wherein said primer pairs are suitable for amplification of SEQ ID NO: 2 and SEQ ID NO: 3, wherein said primer pair for amplification of the nucleic acid region of SEQ ID NO: 2 comprises SEQ ID NO: 10 and SEQ ID NO: 12, wherein said primer pair for amplification of the nucleic acid region of SEQ ID NO: 3 comprises SEQ ID NO:15 and SEQ ID NO:16, and wherein each of said primers comprising SEQ ID NO:10 and SEQ ID NO:15 further comprise a detectable label, and

(ii) one or more E. coli O157:H7 genomic DNA regions outside the pO157 portion of the E. coli O157:H7 genome, wherein said primer pair is suitable for amplification of SEQ ID NO: 1, and wherein said primer pair for amplification of SEQ ID NO: 1 comprises SEQ ID NO:4 and SEQ ID NO:5, and wherein said primer comprising SEQ ID NO:4 further comprises a detectable label;

(b) performing PCR amplification of said nucleic acids of said sample using the reaction mixture of step (a); and

(c) detecting the amplification of step (b), whereby a positive detection of amplification in (a)(i) and (a)(ii) indicates the presence of E. coli O157:H7 in the sample.

2. The method of claim 1 , wherein said reaction mixture further comprises a blocking oligonucleotide capable of quenching said detectable label of said primer comprising SEQ ID NO:10, said blocking oligonucleotide comprising SEQ ID NO:11.

3. The method of claim 1 , wherein the sample comprises a food sample or a water sample.

4. A replication composition for use in performance of PCR, comprising:

(a) a primer pair comprising nucleic acid sequences SEQ ID NO:4 and SEQ ID NO:5;

(b) two or more primer pairs comprising nucleic acid sequences (i) SEQ ID NO:10 and SEQ ID NO:12 and (ii) SEQ ID NO:15 and SEQ ID NO:16; and

(b) thermostable DNA polymerase.

5. The replication composition of claim 4 further comprising a blocking oligonucleotide SEQ ID NO:11.

6. A replication composition for use in performance of PCR, comprising:

(a) a primer pair comprising nucleic acid sequences SEQ ID NO:5 and SEQ ID NO:6;

(b) two or more primer pairs comprising nucleic acid sequences (i) SEQ ID NO:12 and SEQ ID NO:13 and (ii) SEQ ID NO:16 and SEQ ID NO:17; and

(b) thermostable DNA polymerase.

7. The replication composition of claim 6 further comprising one nucleic acid probe for each primer pair selected, wherein said nucleic acid probes comprise SEQ ID NO:7, SEQ ID NO:14, and SEQ ID NO:18.

8. A kit for detection of E. coli O157:H7 in a sample, comprising the replication composition of claim 4 .

9. A kit for detection of E. coli O157:H7 in a sample, comprising the replication composition of claim 6 .

10. A tablet comprising the replication composition of claim 4 .

11. A tablet comprising the replication composition of claim 6 .

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055644/0636 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 41983/0340 Recorded Mar 16, 2021
From: ANTARES CAPITAL LP, AS ADMINISTRATIVE AGENT
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 055628/0366 →
SECURITY INTEREST Recorded Mar 16, 2017
From: QUALICON DIAGNOSTICS LLC, AS THE GRANTOR
To: ARES CAPITAL CORPORATION, AS SECOND LIEN ADMINISTRATIVE AGENT
Reel/Frame 041602/0334 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Mar 13, 2017
From: QUALICON DIAGNOSTICS LLC
To: ANTARES CAPITAL LP, AS FIRST LIEN ADMINISTRATIVE AGENT
Reel/Frame 041983/0340 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2017
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: QUALICON DIAGNOSTICS LLC
Reel/Frame 041468/0214 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2010
From: BURNS, FRANK R.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 024883/0328 →
Continuity (2)
Provisional Application 61227622 · Jul 22, 2009
Related Publication 20110020823A1 · Jan 27, 2011